CRISPR immunity: a case study for justified somatic genetic modification?

Area of Science:

• Biomedical science
• Immunology
• Bioethics

Background:

• The world faces recurrent global pandemics, exemplified by the ongoing SARS-CoV-2 crisis.
• Current biomedical responses primarily focus on treatments and vaccination strategies.
• The need for novel, proactive strategies to bolster population-level immunity is evident.

Purpose of the Study:

• To propose somatic (non-heritable) enhancement of human immunity as an additional pandemic preparedness strategy.
• To explore the feasibility and potential benefits of augmenting individual immune responses.
• To address and counter anticipated bioethical objections to this approach.

Main Methods:

• Conceptual analysis and ethical argumentation.
• Review of existing immunological enhancement concepts.
• Exploration of potential bioethical frameworks for somatic enhancement.

Main Results:

• Somatic immunity enhancement offers a novel, non-heritable approach to pandemic defense.
• Potential methods for somatic enhancement exist and warrant further investigation.
• Bioethical objections, while significant, are surmountable through careful consideration and regulation.

Conclusions:

• Somatic immunity enhancement represents a viable, complementary strategy for future pandemic preparedness.
• Proactive development and ethical consideration of such enhancements are crucial.
• This approach warrants serious consideration by the scientific and public health communities.